Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore

Tuesday, September 2, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

UNION CITY, Calif., Sept. 2 Abaxis, Inc.(Nasdaq: ABAX), a medical products company manufacturing point-of-care bloodanalysis systems, announced today that Clint Severson, CEO and President, willparticipate in the Forbes Global CEO Conference "Best Under a Billion" panelon Tuesday, September 9, 2008 at the Shangri-La Hotel in Singapore.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systemsfor use in any veterinary or human patient-care setting to provide clinicianswith rapid blood constituent measurements. The system consists of a compact,5.1 kilogram (11.2 pounds), portable analyzer and a series of single-useplastic discs, called reagent discs that contain all the chemicals required toperform a panel of up to 13 tests on veterinary patients and 14 tests on humanpatients. The system can be operated with minimal training and performsmultiple routine tests on whole blood, serum or plasma samples. The systemprovides test results in less than 12 minutes with the precision and accuracyequivalent to a clinical laboratory analyzer.Contact: Clint Severson Lytham Partners, LLC Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700 510-675-6500

SOURCE Abaxis, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook